Forum 2023

A Note from Martha S. Samuelson, CEO and Chairman

Dear readers,

The 2023 editions of Forum offer a diverse array of features drawn from our recent publishing and case work in a number of rapidly evolving areas. The articles and Q&As will cover new and continuing trends in antitrust, health care, ESG, digital markets, banking and securities litigation, and consumer and marketing research, among other topics. I hope you will continue to find the ideas and experience we present in these pieces to be engaging, thought-provoking, and useful.

Best wishes,

Martha

Forum

Expert Testimony in Investor-State Disputes

How can economic experts shed light on claimants’ and respondents’ actions and motivations in international investment arbitrations?
Forum

Regulatory Interventions and the Nature of Competition in Digital Ecosystems: A Q&A with Eliana Garces

Do new proposals for regulating platform competition fully account for the unique nature of the digital ecosystem?
Forum

Can Patent Infringement Harm Be Truly Irreparable to an Economist? A Q&A with John Jarosz and Robert Vigil

Courts hearing patent infringement cases often wrestle with the question of how to define irreparable harm in the context of issuing preliminary injunctions.
Forum

If You Build It, Will They Come? Indirect Network Effects and the “Chicken-or-Egg” Dilemma in the Nascent Electric Vehicle Market

AG academic affiliate Erich Muehlegger and Vice President Joseph Cavicchi examine the role of indirect network effects in developing the nascent market for electric vehicles.
Forum

Venture Debt and the Failure of Silicon Valley Bank: A Q&A with Yael Hochberg and Sabrina Howell

Two experts on entrepreneurial finance examine the causes for the collapse of the key Silicon Valley lending institution.
Forum

Confusing? Funny? Just Plain Bad? Surveys and Trademark Litigation After Jack Daniel’s

How surveys might provide evidential weight in trademark litigation after a decision by the US Supreme Court.
Forum

A New “Gold Standard”? How Digital Health Technologies Can Be Used to Monitor Patient Progress

For a client’s clinical study, Analysis Group developed a way to leverage the power of wearable technologies in helping improve care for patients with rheumatoid arthritis and other progressive diseases.
Forum

Fiduciary Duty and ESG: A Q&A with Oliver Hart

The Nobel Prize-winning economist offers a new economic lens for evaluating growing shareholder concerns with ESG issues.
Forum

“A Richer Way to Work”: Martha Samuelson and Andrea Okie Explore the Topic of Women and Diversity in Antitrust

Analysis Group’s CEO and Chairman speaks with Managing Principal Andrea Okie on women’s career paths in antitrust, and why diversity creates a stronger firm.